Cimzia 200 mg (Certolizumab pegol 200 mg / 1 ml) by UCB Pharma.
Indications: Rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, plaque psoriasis (and Crohn's disease in some markets).
Administration: Subcutaneous: 400 mg at weeks 0, 2 and 4, then 200 mg every 2 weeks.
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | UCB Pharma |
| Active ingredient | Certolizumab pegol 200 mg / 1 ml — PEGylated anti-TNF-α Fab' fragment. |
| Strength & pack | 2 pre-filled syringes (or pens) + alcohol wipes. |
| Form | Solution for injection in pre-filled syringe/pen |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |